Advertisement
Screener

DREAM FINDERS HOMES, INC. (DFH) Spending and interest coverage

DREAM FINDERS HOMES, INC. (DFH) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.51%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months0.51%Share-based compensation / revenue. Period ending 2026-06-30.

$20.97M ÷ $4.13B × 100 ≈ 0.51%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue4.13B USD
Stock-based compensation20.97M USDShare-based Payment Arrangement, Noncash Expense
Operating income(m)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$4.13B$20.97M(m)(m)(m)0.51%(m)(m)
2026-03-31(m)$4.22B$20.70M(m)(m)(m)0.49%(m)(m)
2025-12-31(m)$4.32B$24.92M(m)(m)(m)0.58%(m)(m)
2025-09-30(m)$4.67B$25.15M(m)(m)(m)0.54%(m)(m)
2025-06-30(m)$4.71B$25.02M(m)(m)(m)0.53%(m)(m)
2025-03-31(m)$4.61B$24.78M(m)(m)(m)0.54%(m)(m)
2024-12-31(m)$4.45B$18.79M(m)(m)(m)0.42%(m)(m)
2024-09-30(m)$4.03B$17.47M(m)(m)(m)0.43%(m)(m)
2024-06-30(m)$3.92B$16.15M(m)(m)(m)0.41%(m)(m)
2024-03-31(m)$3.81B$15.13M(m)(m)(m)0.40%(m)(m)
2023-12-31(m)$3.75B$14.10M(m)(m)(m)0.38%(m)(m)
2023-09-30(m)$3.71B$12.26M(m)(m)(m)0.33%(m)(m)
2023-06-30(m)$3.60B$10.03M(m)(m)(m)0.28%(m)(m)
2023-03-31(m)$3.45B$7.86M(m)(m)(m)0.23%(m)(m)
2022-12-31(m)$3.34B$6.80M(m)$32.00K(m)0.20%(m)Reported
2022-09-30(m)$3.09B$6.02M(m)$31.17K(m)0.19%(m)Reported
2022-06-30(m)$2.67B$5.92M(m)$40.17K(m)0.22%(m)Reported
2022-03-31(m)$2.24B$5.49M(m)$43.17K(m)0.24%(m)Reported
2021-12-31(m)$1.92B$5.23M(m)$672.17K(m)0.27%(m)Reported
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)$1.13B$946.61K(m)$870.87K(m)0.08%(m)Reported
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31(m)$744.29M$895.00K(m)$221.45K(m)0.12%(m)Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.